Yikon Genomics
Yikon Genomics is a Shanghai-based reproductive genetics company founded in 2012 that sells PGT assays, reagent kits, and integrated NGS-based lab solutions to fertility clinics, reproductive medical centers, and clinical laboratories across 40+ countries through 1,488+ partners.
- Company typePrivate
- Founded2012
- HeadquartersMinhang, China
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Yikon Genomics firmographics
Firmographics- Name
- Yikon Genomics
- Legal name
- Yikon Genomics (Suzhou) Co., Ltd
- Website
- https://yikongenomics.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Yikon Genomics is a Shanghai-based reproductive genetics company founded in 2012 that sells PGT assays, reagent kits, and integrated NGS-based lab solutions to fertility clinics, reproductive medical centers, and clinical laboratories across 40+ countries through 1,488+ partners.
- Ownership category
- akta.pro rank
Yikon Genomics industry classification
Industry- Product category
- Reproductive Genetic Testing
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
- akta.pro secondary industries
- Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where Yikon Genomics is headquartered
LocationHeadquarters
- HQ city
- Minhang
- HQ country
- China
- HQ region
- Asia
Offices7 records
Markets served
Yikon Genomics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Reagent Kits, Instruments and Consumables Sales: Sale of proprietary reagent kits including MALBAC® Single Cell WGA Kit, ChromInst™ Universal Library Normalization Kit, NGS Library Preparation Kits, and other consumables for genetic testing workflows
- Integrated Lab Solutions: Providing comprehensive solutions including reagents, software and SOPs to enable embryo and endometrium testing on any NGS platform in a single run
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Yikon Genomics product offering
Product offeringCore offering
Yikon Genomics develops, manufactures, and sells proprietary preimplantation genetic testing (PGT) products and reagent kits used by fertility clinics and medical laboratories for reproductive health applications. Its portfolio includes ChromInst® PGT-A, NICS® non-invasive testing, MaReCs® for structural rearrangements, PGT-M (MARSALA) for monogenic disorders, KaryoSeq™, and ERT® endometrial receptivity testing, supported by an Integrated Lab Solution that bundles reagents, software, SOPs, and lab design services to enable testing on any NGS platform.
Differentiator
Problem solved
Functional benefit
Brands
- MALBAC: Single-cell whole-genome amplification technology - Harvard-licensed patent with more uniform amplification and higher coverage (93%)
- ChromInst
- MaReCs
- NICS
- ERT
Products and services
- ChromInst® PGT-A Preimplantation Genetic Testing for Aneuploidies using single-cell one-step library technology that combines amplification and sequencing library construction into a single process, reducing PGT-A testing time to 5 hours; for IVF clinics and reproductive medicine laboratories.
- NICS® Non-invasive Preimplantation Genetic Testing for Aneuploidies that uses blastocyst culture medium instead of biopsy cells, offering a non-invasive approach for embryo chromosome screening; for fertility clinics and IVF centers.
- MaReCs® Preimplantation Genetic Testing for Structural Rearrangement that integrates single-cell amplification, breakpoint detection, and copy number variation (CNV) analysis in one step to diagnose embryo carrier status; for reproductive medicine clinics.
- PGT-M (MARSALA) Pre-implantation Genetic Testing for Monogenic Disorders using one-step sequencing that detects gene loci, aneuploidies, and SNP sites; for fertility clinics serving couples with inherited disease risk.
- KaryoSeq™ Preimplantation genetic testing product for karyotype sequencing, enabling comprehensive chromosomal analysis of embryos; for reproductive health laboratories.
- ICS® PGT-SR Preimplantation Genetic Testing for Structural Rearrangement enabling detection of chromosomal structural abnormalities in embryos; for assisted reproduction clinics.
- ERT® Endometrium Receptivity Test Endometrium Receptivity Test using RNA-seq integrated with AI analysis for precise determination of endometrial receptivity to support embryo transfer timing; for IVF clinics and infertility specialists.
- ERT Transplant Time Calculator Digital tool to calculate optimal endometrium transplant timing based on ERT analysis results; for reproductive medicine clinicians performing embryo transfers.
- MALBAC® Single Cell WGA Kit Single-cell whole-genome amplification kit leveraging Harvard-licensed MALBAC® patent technology for preprocessing genetic samples prior to sequencing analysis, providing 93% coverage uniformity; for clinical and research genetic testing laboratories.
- MALBAC® Single Cell DNA Quick-Amp Kit Quick amplification kit for single-cell DNA samples enabling rapid whole-genome amplification; for genetic testing laboratories.
- Micro RNA Sample Preparation Kit Kit for preparation of micro RNA samples for downstream sequencing applications; for NGS laboratories performing reproductive and genetic screening workflows.
- NGS Library Preparation Kit Complete kit for preparing sequencing libraries compatible with next-generation sequencing platforms; for genetic testing laboratories.
- Universal Library Preparation Kit Versatile library preparation kit suitable for various sample types and sequencing applications; for clinical and research genetic testing laboratories.
- NGS Universal Index Kit Indexing kit for multiplexed NGS library preparation enabling sample pooling; for genetic testing laboratories.
- NGS Universal Dual Index Kit Dual indexing solution for NGS library preparation to minimize index hopping and cross-contamination; for clinical genetic testing laboratories.
- ChromInst™ Universal Library Normalization Kit Kit for normalizing library concentrations across samples to ensure consistent sequencing depth; for NGS-based reproductive genetic testing workflows.
- DNA Fragmentation Kit Kit for fragmenting DNA samples to optimal sizes for library preparation and sequencing; for genetic testing laboratories.
- Pre-amplification Buffer Kit Buffer solution for pre-amplification steps in sample processing workflows; for genetic testing laboratories.
- Sample Preservation Buffer
Quantifiable outcome
- 93% coverage uniformity with single-cell whole-genome amplification technology
- +2 more outcomes
Companies that use Yikon Genomics
Customer profileSegments3 records
Ideal customer profiles3 records
Yikon Genomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Yikon Genomics partnerships and signals
Strategic signalScale indicators5 records
Yikon Genomics competitors and assessment
Company assessmentDirect peers
- Natera: Natera's Spectrum PGT-A, PGT-M, and Empower carrier screening compete head-to-head with Yikon's PGT portfolio in fertility clinics globally. Both companies sell integrated genetic testing solutions to IVF centers with strong brand recognition among reproductive endocrinologists.
- Igenomix (Vitrolife): Igenomix, now part of Vitrolife, is one of the largest global reproductive genetics labs offering PGT-A, PGT-M, and endometrial receptivity (ERA), directly overlapping with Yikon's ChromInst, MARSALA, and ERT product lines.
- BGI Genomics: BGI is a China-headquartered genomics giant offering NIFTY NIPT, PGT, and clinical sequencing services. It is the most direct domestic Chinese competitor to Yikon with overlapping reproductive genetics products and integrated lab services.
Broad incumbents
- Illumina: Illumina is the dominant NGS platform provider whose sequencing instruments underpin nearly all PGT workflows including Yikon's. It also sells its own VeriSeq PGT-A assay and recently acquired GRAIL, making it both a critical infrastructure partner and a competitor.
- Thermo Fisher Scientific: Thermo Fisher offers reproductive health products through its specialty diagnostics segment and supplies NGS reagents and instruments broadly. Its scale and global sales reach make it a structural competitor to Yikon's reagent and integrated lab solution offerings.
- Revvity (formerly PerkinElmer): Revvity offers reproductive health screening including carrier screening and NIPT, and historically supplied Vanadis NIPT platform. Its broad reproductive diagnostics portfolio overlaps with several of Yikon's offerings.
- Myriad Genetics: Myriad offers Foresight carrier screening and Prequel NIPT, serving reproductive health providers with a similar clinical channel as Yikon. While less focused on PGT, it competes for reproductive health wallet share with genetic testing menus.
Emerging players
- Genea Biomedx: Genea Biomedx focuses on IVF lab instruments and consumables. While primarily equipment-focused rather than PGT-centric, it serves the same fertility clinics and competes for integrated lab solution budgets alongside Yikon.
Regional players
- KingMed Diagnostics: KingMed is a strategic investor in Yikon and one of China's largest independent medical laboratory networks. It is also a competitor in clinical sequencing and reproductive health diagnostics within China, making it a regionally focused peer with channel overlap.
- Yisheng Bio: Yisheng Bio is a Chinese specialty diagnostics company with NIPT and reproductive health offerings. It competes with Yikon primarily in the China market for genetic testing service contracts with hospitals and fertility clinics.
Market position
Customer concentration
Yikon Genomics social profiles
Digital presenceYikon Genomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yikon Genomics leadership team
Management profileNumber of profiles
Profiles1 record
Yikon Genomics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yikon Genomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yikon Genomics
What does Yikon Genomics do?
Yikon Genomics develops, manufactures, and sells proprietary preimplantation genetic testing (PGT) products and reagent kits used by fertility clinics and medical laboratories for reproductive health applications. Its portfolio includes ChromInst® PGT-A, NICS® non-invasive testing, MaReCs® for structural rearrangements, PGT-M (MARSALA) for monogenic disorders, KaryoSeq™, and ERT® endometrial receptivity testing, supported by an Integrated Lab Solution that bundles reagents, software, SOPs, and lab design services to enable testing on any NGS platform.
Is Yikon Genomics a public or private company?
Yikon Genomics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Yikon Genomics founded?
Yikon Genomics was founded in 2012. It employs 501 to 1,000 people.
Where is Yikon Genomics based?
Yikon Genomics is headquartered in Minhang, China, in the Asia region.
How does Yikon Genomics make money?
Two revenue lines are on record. Reagent Kits, Instruments and Consumables Sales are the primary driver. The others are integrated Lab Solutions.
Who are Yikon Genomics's main competitors?
Direct peers on record are Natera, Igenomix (Vitrolife) and BGI Genomics. Broad incumbents are Illumina, Thermo Fisher Scientific, Revvity (formerly PerkinElmer) and Myriad Genetics. Genea Biomedx is listed as an emerging player. Regional players are KingMed Diagnostics and Yisheng Bio.
Does Yikon Genomics have an API?
No public API is recorded for Yikon Genomics.
What industry is Yikon Genomics in?
Yikon Genomics's product category is Reproductive Genetic Testing. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD. Its NAICS code is 62151 and its SIC code is 2835.